| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Jul―08 |
Isolation and computational characterization of a novel cyanogenic glucoside from Centaurea microcarpa with antiviral potential against SARS-CoV-2: DFT, ADMET, and molecular docking analysis |
Rachida Kerkour, Samia Baatouche, Abir Boublia, Nadjib Chafai, Ramadan Seghiri, Djamel Sarri |
| 2 |
[GO] |
2025―Jun―02 |
Utilizing natural compounds as ligands to disrupt the binding of SARS-CoV-2 receptor-binding domain to angiotensin-converting enzyme 2, impeding viral infection |
Jingyi Wu, Ting-Hsu Chen, Zi-han Shen, May-Jywan Tsai, Max K. Leong, Yan-qiang Huang, Ching-Feng Weng |
| 3 |
[GO] |
2025―Mai―31 |
Molecular docking and network pharmacology highlight salvianolic acids as potential inhibitors and therapeutic agents for COVID-19 treatment |
Anathi Msobo, Manamele Dannies Mashabela, Gerrit Koorsen, Teboho Nicolus Tsotetsi, Lizelle Ann Piater, Ntakadzeni Edwin Madala, et al. (+2) Tendamudzimu Tshiwawa, Msizi Innocent Mhlongo |
| 4 |
[GO] |
2024―Aug―13 |
Biodiversity and emergence of viral pandemics |
Bruno David |
| 5 |
[GO] |
2023―Jul―07 |
Structural characterization and SARS-CoV-2 inhibitory effects of alkaloids from the roots of Asarum heterotropoides var. mandshuricum (Aristolochiaceae) |
Thi Thanh Le, Thao Quyen Cao, Manh Tuan Ha, Kang-Hyun Han, Yong-Bum Kim, Jeong Ah Kim, Byung Sun Min |
| 6 |
[GO] |
2022―Aug―02 |
Synthesis and Evaluation of Diterpenic Mannich Bases as Antiviral Agents against Influenza A and SARS-CoV-2 |
Elena V. Tret’yakova, Xinyuan Ma, Oxana B. Kazakova, Anna A. Shtro, Galina D. Petukhova, Artem M. Klabukov, et al. (+4) Danil S. Dyatlov, Anna A. Smirnova, Huan Xu, Sulong Xiao |
|
